Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FE 999049 dosing in long GnRH agonist versus GnRH antagonist IVF stimulation protocols
NL-OMON52678Phase 3Active, not recruiting
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of recombinant human follicle stimulating hormone in infertility (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Number of oocytes retrieved. Started Jun 2019; status: active, not recruiting.
02
Drugs
recombinant human follicle stimulating hormone
03
Conditions
infertility
Beyond the preview
Go deeper on NL-OMON52678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52678.